Janux Therapeutics, Inc. (JANX) — Capital Expenditures
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.04M | +190.5% |
| 2024 | $359.0K | -80.6% |
| 2023 | $1.85M | -71.3% |
| 2022 | $6.45M | +334.9% |
| 2021 | $1.48M | — |
| 2020 | $0 | — |
| Fiscal Year | Capital Expenditures | Change YoY |
|---|---|---|
| 2025 | $1.04M | +190.5% |
| 2024 | $359.0K | -80.6% |
| 2023 | $1.85M | -71.3% |
| 2022 | $6.45M | +334.9% |
| 2021 | $1.48M | — |
| 2020 | $0 | — |